Fulgent Genetics, Inc. (FLGT)
15.95
+0.10
(+0.63%)
USD |
NASDAQ |
May 19, 16:00
15.96
+0.02
(+0.09%)
After-Hours: 20:00
Fulgent Genetics Shareholders Equity (Quarterly) : 1.050B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 7.366B |
| Labcorp Holdings, Inc. | 8.729B |
| Psychemedics Corp. | -- |
| Guardant Health, Inc. | -181.07M |
| Castle Biosciences, Inc. | 461.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.156B |
| Total Liabilities (Quarterly) | 112.22M |
| Debt to Equity Ratio | 0.0097 |
| Current Ratio | 5.315 |
| Net Debt Paydown Yield | -0.04% |